Table 3.
List of the AMPs in ongoing clinical trials.
| AMP | Peptide structural characteristic | Ongoing Clinical Trials |
|---|---|---|
| Bacitracin | Natural cyclic peptide | Phase IV |
| Pexiganan | Natural linear peptide | Phase III |
| Omiganan | Indolicidin derivative peptide | Phase III |
| LL-37 | Natural α-helical peptide | Phase II |
| LTX-109 | Synthetic Antimicrobial Peptidomimetic | Phase II |
| Brilacidin | Synthetic peptide | Phase II |